- Study Supports Long-Term Efficacy of Esketamine Nasal Spray in Patients With TRD Psychiatric Times
- Spravato Safety Holds Up Long-Term for Treatment-Resistant Depression Medpage Today
- Study Compares Work Productivity Loss, Cost Savings in Esketamine Nasal Spray vs Quetiapine Extended-Release for TRD Psychiatric Times
- View Full coverage on Google News
from Health - Latest - Google News
0 comments:
Post a Comment